Expert Radar
Dr. Mitchell Machtay, MD, FASTRO
Dr. Mitchell Machtay, MD, FASTRO
Associate Director, Case Comprehensive Cancer Center (Cleveland, OH)
Bachelor of Science, Princeton University
Dr. Mitchell Machtay has over 31 years of experience in the field of Radiation Oncology. He earned his BS in Chemical Engineering from Princeton University and his MD from NYU Grossman School of Medicine. He completed his residency in Radiation Oncology at Radiation Oncology. Today, this expert is board certified in Radiation Oncology. Formerly, he served as the Walter J. Curran Jr. Professor and Vice Chair in the Department of Radiation Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and the Vincent K. Smith Professor and Chair in the Department of Radiation Oncology at Case Western Reserve University School of Medicine. Currently, he serves as the Associate Dean for Clinical Cancer Research and the Professor and Endowed Chair in Cancer Clinical Research in the Department of Radiation Oncology at Penn State College of Medicine and Attending Physician in Radiation Oncology at Penn State Health Milton S. Hershey Medical Center. He also served as the Associate Director for Clinical Research at Penn State Cancer Institute.
m*********@u*****.org
(717) ***-****
Hershey, Pennsylvania
Get a FREE Demo of Dr. Mitchell Machtay, MD, FASTRO's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
253
Media & News
486
Social Media Mentions
6
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|---|---|
Wanda K Leinweber v. Clinton Henry Leinweber Jr., et al. | Fact/ Lay Witness | 2019-04-25 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 253 records
Title | Type |
|---|---|
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer | Journal Article |
A Pilot Trial of Proton-Based Cardiac Sparing Accelerated Fractionated Radiation Therapy in Unresectable Non-small Cell Lung Cancer With Extended Durvalumab Therapy (PARTICLE-D) | Journal Article |
Outcomes of initial therapy for synchronous brain metastases from small cell lung cancer: a single-institution retrospective analysis | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 486 records
Title | Description |
|---|---|
Postoperative RT Plus Cetuximab Showed Mixed Results ... | Feb 3, 2025 ----- This study was led by Mitchell Machtay , MD, Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania . It was published ... |
Cetuximab Plus RT Benefits Some with Head and Neck ... | Jan 30, 2025 ----- This study was led by Mitchell Machtay , MD, Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania. It was published ... |
Addition of Cetuximab to Postoperative Radiotherapy in ... | Jan 28, 2025 ----- Radiotherapy [+ cetuximab] is an appropriate option for carefully selected patients with HPV-negative disease. Mitchell Machtay , MD, Penn State ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
Princeton University | Bachelor of Science |
NYU Grossman School of Medicine | Doctor of Medicine |
Work History
Title | Employer |
|---|---|
Associate Director | Case Comprehensive Cancer Center (Cleveland, OH) |
Attending Physician | University Hospitals Health System (Cleveland, OH) |
Attending Physician | Penn State Health (Hershey, PA) |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3–5 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
